CVS Corp (CVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,854,000 | 5,683,000 | 4,059,000 | 1,696,000 | 3,371,000 |
| Marketable Securities | 3,000,000 | 2,373,000 | 2,522,000 | 111,000 | 87,000 |
| Receivables | 21,742,000 | 19,617,000 | 17,631,000 | 13,181,000 | 12,164,000 |
| Inventories | 18,496,000 | 17,516,000 | 16,450,000 | 15,296,000 | 14,760,000 |
| Other current assets | 5,277,000 | 5,113,000 | 4,581,000 | 945,000 | 660,000 |
| TOTAL | $56,369,000 | $50,302,000 | $45,243,000 | $31,229,000 | $31,042,000 |
| Non-Current Assets | |||||
| PPE Net | 12,606,000 | 12,044,000 | 11,349,000 | 10,292,000 | 10,175,000 |
| Investments And Advances | 20,812,000 | 17,314,000 | 15,732,000 | 112,000 | 0 |
| Intangibles | 110,694,000 | 112,870,000 | 115,202,000 | 52,081,000 | 51,760,000 |
| Other Non-Current Assets | 30,234,000 | 29,919,000 | 8,930,000 | 1,417,000 | 1,485,000 |
| TOTAL | $174,346,000 | $172,147,000 | $151,213,000 | $63,902,000 | $63,420,000 |
| Total Assets | $230,715,000 | $222,449,000 | $196,456,000 | $95,131,000 | $94,462,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,440,000 | 3,781,000 | 1,985,000 | 4,821,000 | 1,916,000 |
| Accounts payable and accrued liabilities | 34,869,000 | 30,972,000 | 26,437,000 | 19,223,000 | 17,397,000 |
| Accrued Expenses | 14,243,000 | 12,133,000 | 10,711,000 | 6,581,000 | 6,937,000 |
| Other current liabilities | 5,827,000 | 4,821,000 | 4,876,000 | 23,000 | N/A |
| TOTAL | $62,017,000 | $53,303,000 | $44,009,000 | $30,648,000 | $26,250,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 59,207,000 | 64,699,000 | 71,444,000 | 22,181,000 | 25,615,000 |
| Other Non-Current Liabilities | 32,983,000 | 32,986,000 | 14,785,000 | 1,610,000 | 1,547,000 |
| TOTAL | $98,997,000 | $104,976,000 | $93,904,000 | $26,788,000 | $31,378,000 |
| Total Liabilities | $161,014,000 | $158,279,000 | $137,913,000 | $57,436,000 | $57,628,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,311,355 | 1,304,160 | 1,297,082 | 1,014,532 | 1,025,700 |
| Common Shares | 46,513,000 | 45,972,000 | 45,440,000 | 32,096,000 | 17,000 |
| Retained earnings | 49,640,000 | 45,108,000 | 40,911,000 | 43,556,000 | 38,983,000 |
| Other shareholders' equity | 1,726,000 | 1,325,000 | 420,000 | -161,000 | -332,000 |
| TOTAL | $69,701,000 | $64,170,000 | $58,543,000 | $37,695,000 | $36,834,000 |
| Total Liabilities And Equity | $230,715,000 | $222,449,000 | $196,456,000 | $95,131,000 | $94,462,000 |